Angiotensin Converting Enzyme Inhibitors versus Receptor Blockers in Patients with Ventricular Tachyarrhythmias

Data investigating the prognostic value of treatment with angiotensin converting enzyme inhibitors (ACEi) and receptor blockers (ARB) usually focusses on patients presenting with heart failure (HF) or acute myocardial infarction (AMI). However, by preventing adverse cardiac remodeling, ACEi/ARB may...

Descripción completa

Detalles Bibliográficos
Autores principales: Schupp, Tobias, Behnes, Michael, Abumayyaleh, Mohammad, Weidner, Kathrin, Mashayekhi, Kambis, Bertsch, Thomas, Akin, Ibrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910841/
https://www.ncbi.nlm.nih.gov/pubmed/35268553
http://dx.doi.org/10.3390/jcm11051460

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8910841/
https://www.ncbi.nlm.nih.gov/pubmed/35268553
http://dx.doi.org/10.3390/jcm11051460

Ejemplares similares